IRIS
TARAMASSO, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.764
Totale 7.764
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 7.764
Totale 7.764
Salva come PNG Salva come JPEG
Città #
Genova 5.419
Rapallo 1.163
Genoa 1.094
Bordighera 44
Vado Ligure 44
Totale 7.764
Salva come PNG Salva come JPEG
Nome #
Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy 240
CD8+CD28-CD127loCD39+regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection? 176
Is it still worthwhile to perform quarterly CD4+ T lymphocyte cell counts on HIV-1 infected stable patients? 164
Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status. 150
Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir. 148
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 144
Pharmacokinetics of Lopinavir Determined with an ELISA Test in Youths with Perinatally Acquired HIV. 139
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 132
Bloodstream infections in patients living with HIV in the modern cART era 131
Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital: a 30-year retrospective study 129
Will new antimicrobials overcome resistance among Gram-negatives? 119
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. 114
Which patients have greatest need for elvitegravir/cobicistat/ emtricitabine/tenofovirDF-based therapy? 112
Chemotherapy Mass Campaigns and Migratory Flows: An Unexpected Connection 111
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients 110
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Diagnosis and Treatment of Sarcoidosis in an HIV-2-Infected Patient. 104
Reducing CD4+ lymphocyte cell monitoring in HIV-1 stable patients: a forecast of the cost saving 103
Successful recovery of associated interstitial nephritis and focal segmental glomerulosclerosis in patients with HCV and HIV treated with sofosbuvir and daclatasvir and revision of literature 102
Bedaquiline: A new hope for shorter and better anti-tuberculosis regimens 102
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 99
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 99
Increasing prevalence of genitourinary schistosomiasis in Europe in the Migrant Era: Neglected no more? 97
Time to change the single-centre approach to management of patients with tuberculosis: a novel network platform with automatic data import and data sharing 95
AUMENTO DEGLI INDICI DI CITOLISI EPATICA NEI SOGGETTI CON INFEZIONE DA HIV CHE AVVIANO LA PRIMA LINEA DI TRATTAMENTO ANTIRETROVIRALE: STUDIO OSSERVAZIONALE DI COORTE 95
How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy 95
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 93
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 93
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 93
How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis 90
Patient-reported outcomes and low-level residual HIV-RNA in adolescents perinatally infected with HIV-1 after switching to one-pill fixed-dose regimen. 90
Rationale for an association between PD1 checkpoint inhibition and therapeutic vaccination against HIV 89
Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglycerides 88
Pineal Germinoma in a Child with Interferon-γ Receptor 1 Deficiency. Case Report and Literature Review 88
Ibalizumab and fostemsavir in the management of heavily pre-treated HIV-infected patients 87
Onychomadesis in a male patient with secondary syphilis 86
Factors associated with hospital admission for COVID-19 in HIV patients 84
Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/ emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: Different effects in patients with or without baseline hypercholesterolemia 83
Weight gain: A possible side effect of all antiretrovirals 82
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 81
Is it time to re-think the use of etravirine in patients with available genotypic resistance test? 80
Bloodstream infections in critically ill patients with COVID-19 80
Short Communication: Tenofovir Disoproxil Fumarate/Emtricitabine Fits for All as Appropriate HIV-1 Pre-Exposure Prophylaxis? 79
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 79
Treatment of hepatitis C virus genotype 4 in the DAA era 78
HIV-1 RNA quantification in CRF02_AG HIV-1 infection: too easy to make mistakes 77
Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave? 77
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals 77
Hepatitis C virus direct acting antivirals impact on renal function in the first 4 weeks of treatment 76
Co-infezione HIV/HCV e malattia renale: un binomio “scindibile” 76
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells 75
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 74
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 73
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? 72
Therapeutic management of chronic hepatitis B in clinical Practice: a region-wide survey. 70
HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation 67
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors 67
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 66
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study 64
Missed opportunities to prevent mother-to-child transmission of HIV in Italy 63
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 63
Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: different effects in different patients populations. Results from a large observational study 61
Bloodstream infections in patients living with HIV infection in the recent cART era: did something change?”. 61
Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia 61
Ligurian Vaccination in HIV Program (LIV in HIV): the experience of Genoa metropolitan area 60
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 60
Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected Patients 59
Increasing use and accessibility of anti parasitic drugs for migrants with neglected diseases at a time of migratory emergency 58
Use of quantitative ultrasound as bone mineral density evaluation in an Italian female population living with HIV: A real-life experience 58
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 58
Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study 57
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: The HIVand Hypertension Study 56
HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation 56
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study 51
HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation 49
null 49
Bloodstream infections in HIV-infected patients 48
Immunological profile of an infant treated with integrase inhibitor from the neonatal period 47
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 47
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 46
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study 46
Spread of carbapenem-resistant gram-negatives and candida auris during the covid-19 pandemic in critically ill patients: One step back in antimicrobial stewardship? 44
Viremia copy-years and risk of estimated glomerular filtration rate reduction in adults living with perinatal HIV infection 42
Duration of isolation and precautions in immunocompromised patients with COVID-19 42
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients 41
Injectable Antiretroviral Drugs: Back to the Future 41
Darunavir e incremento del peso corporeo: due diversi booster, stessi risultati 40
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection 40
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region 39
Higher mortality and intensive care unit admissions in COVID-19 patients with liver enzyme elevations 38
Real-World Analysis of Survival and Clinical Events in a Cohort of Italian Perinatally HIV-1 Infected Children From 2001 to 2018 38
Role of raltegravir in patients co-infected with HIV and HCV in the era of direct antiviral agents 33
COVID-19: Some clinical questions after the first 4 months 33
Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy 33
Is a step-down antiretroviral therapy necessary to fight severe acute respiratory syndrome coronavirus 2 in HIV-infected patients? 30
Functional tricuspid regurgitation: The increasing clinical importance of the "forgotten valve" 29
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 28
The switch from tenofovir disoproxil fumarate to tenofovir alafenamide determines weight gain in patients on rilpivirine-based regimen 28
Viremia copy-years and risk of estimated glomerular filtration rate reduction in adults living with perinatal HIV infection 27
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 25
Missed opportunities in tb clinical practice: How to bend the curve? A medical, social, economic and ethical point of view 25
Totale 7.654
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.103
article - articoli 30.121
book - libri 0
conference - conferenze 616
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 110
Totale 61.950
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.185 159 54 37 137 192 233 342 207 231 326 196 71
2020/20211.332 50 137 253 109 84 84 75 120 73 130 65 152
2021/20221.201 48 39 59 138 51 98 57 270 105 126 50 160
2022/20231.434 119 115 11 130 175 195 64 105 209 109 178 24
2023/2024922 39 94 13 111 68 146 71 64 43 25 98 150
2024/202575 75 0 0 0 0 0 0 0 0 0 0 0
Totale 8.109